Yahoo Web Search

Search results

1. • • Jean-Charles Soria is Amgen’s senior vice president of Oncology within Global Development. Soria joins Amgen from Institut Gustave Roussy, where he was appointed director general by France’s minister of health and solidarity. Soria is a medical oncologist and professor of medicine at Paris-Saclay University.
     www.amgen.com/about/leadership/senior-management/jean-charles-soria

     Jean-Charles Soria - Amgen

2. People also ask

   Who is Jean-Charles Soria?

   • Jean-Charles Soria is Amgen’s senior vice president of Oncology within Global Development. Soria joins Amgen from Institut Gustave Roussy, where he was appointed director general by France’s minister of health and solidarity. Soria is a medical oncologist and professor of medicine at Paris-Saclay University.

   Jean-Charles Soria - Amgen

   www.amgen.com/about/leadership/senior-management/jean-charles-soria

   See all results for this question

   Who is John Soria?

   • He has contributed to first-in-man trials of atezolizumab and pembrolizumab in lung cancer. Dr. Soria has been a member of the AACR since 1998 and has regularly presented work at AACR Annual meetings since 1999. In 2001, Dr. Soria won the AACR-AFLAC Scholar in Training Award, which provides grants to promising young investigators.

   Jean-Charles Soria - American Association for Cancer Research

   aacrjournals.org/pages/researcher-bio-jean-charles-soria

   See all results for this question

   Who is Professor Soria?

   • Over the last three years, Professor Soria has appeared in the list of the most influential research scientists in the world (Web of Science Group’s highly cited researchers). He is author or co-author of more than 630 articles in leading international journals.

   Jean-Charles Soria - Gustave Roussy

   www.gustaveroussy.fr/en/jean-charles-soria

   See all results for this question

   What does Dr Soria do?

   • His work focuses on potential therapeutic treatments for cancer, especially in precision medicine and immuno-oncology. He has contributed to first-in-man trials of atezolizumab and pembrolizumab in lung cancer. Dr. Soria has been a member of the AACR since 1998 and has regularly presented work at AACR Annual meetings since 1999.

   Jean-Charles Soria - American Association for Cancer Research

   aacrjournals.org/pages/researcher-bio-jean-charles-soria

   See all results for this question

   What does Professor Soria do at AstraZeneca?

   • Since September 2017, Professor Soria has been Senior Vice-President, Research & Development in Oncology, with AstraZeneca in Gaithersburg, Maryland, United States, where he leads research teams responsible for strategy and for development of new agents in immuno-oncology, cell therapy and conjugated antibodies.

   Jean-Charles Soria - Gustave Roussy

   www.gustaveroussy.fr/en/jean-charles-soria

   See all results for this question

3. www.esmo.org › biographies › jean-charles-soriaJean-Charles Soria | Editor-in-Chief of Annals of Oncology - ESMO

   www.esmo.org › biographies › jean-charles-soria

   • Cached

   Jean-Charles Soria is a Professor of Medicine and Medical Oncology at South-Paris University. He is a tenure-track and full-time cancer specialist at Institut Gustave Roussy. Dr Soria trained as a medical oncologist and obtained the Silver medal from Paris Medical School in 1997.

4. Images

   • 
   • 
   • 
   • 
   • 

   View all

5. www.linkedin.com › in › jean-charles-soria-md-phdJean-Charles Soria, MD, PhD - Amgen | LinkedIn

   www.linkedin.com › in › jean-charles-soria-md-phd

   View Jean-Charles Soria, MD, PhD’s profile on LinkedIn, a professional community of 1 billion members. I am Amgen's Oncology Therapeutic Area Head and a Senior Vice President in charge of…

   • Connections: 500+
   • Works For: Amgen

   • Followers: 25K
   • Location: United States

6. www.gustaveroussy.fr › en › jean-charles-soriaJean-Charles Soria - Gustave Roussy

   www.gustaveroussy.fr › en › jean-charles-soria

   • Cached

   Professor Jean-Charles Soria. General Director of Gustave Roussy from January 2020 to august 2021. Professor Jean-Charles Soria is a Medical Oncologist and Professor of Medicine at Paris-Saclay University. He holds a doctorate in molecular biology.

7. Videos

   • 

     8:54

     dailymotion.com

     Entretien avec le Pr. Jean Charles SORIA lors du sympo WIN

     24 Jul 2009

     15 views

   • 

     6:15

     youtube.com

     ASCO 2010: Systemic therapy - what lies ahead?

     28 Jul 2010

     504 views

   • 

     3:15

     dailymotion.com

     En direct de L'ASCO14, interview du Pr. Jean-Charles Soria par Alain Perez Décision Santé.

     4 Jun 2014

     1 views

   View all

8. www.ceoroundtableoncancer.org › team › jean-charlesJean-Charles Soria, MD, PhD - CEO Roundtable

   www.ceoroundtableoncancer.org › team › jean-charles

   • Cached

   Jean-Charles Soria is Amgen’s Senior Vice President of Oncology within Global Development. Soria joined Amgen from Institut Gustave Roussy, where he was appointed director general by France’s Minister of Health and Solidarity.

9. archive.cancerworld.net › cover-story › jean-charlesJean-Charles Soria: Beyond the science - Cancer World Archive

   archive.cancerworld.net › cover-story › jean-charles

   • Cached

   Mar 1, 2014 · When we meet at his office at the Gustave Roussy Cancer Centre, Paris, where he is full-time cancer specialist and Chair of the Drug Development Department (DITEP), Jean-Charles Soria hurries through the state of the art medicine. The impressive career history is mere background.

10. aacrjournals.org › pages › researcher-bio-jeanJean-Charles Soria - American Association for Cancer Research

    aacrjournals.org › pages › researcher-bio-jean

    • Cached

    Jean-Charles Soria is a newly appointed Deputy Editor of Clinical Cancer Research and is currently a Senior Vice President and Head of the Oncology Innovative Medicines unit (iMED) at MedImmune, where he has overall responsibility for the global oncology portfolio with oversight of research, translational sciences, and clinical development in ...